Search
Search Constraints
You searched for: Author/Creator Zheng, Ming-YingLimit your search
- Zheng, Ming-Ying [remove] 2
- 616.99424 2
- Electronic journals 2
- Lung Neoplasms -- Abstracts 2
- Lung Neoplasms -- Periodicals 2
- Lungs -- Cancer 2
- Lungs -- Cancer -- Periodicals 2
- Periodicals 2
- Poumons -- Cancer -- Périodiques 2
- EGFR-Mutant -- Non-small cell lung cancer -- Small-cell lung cancer -- Transformation -- Immune checkpoint inhibitors 1
- T-SCLC Transformed small-cell lung cancer -- WES Whole-exome sequencing -- ABCP Atezolizumab-bevacizumab-carboplatin-paclitaxel (albumin-bound) -- ECT Atezolizumab-etoposide-carboplatin -- mPFS Median progression-free survival -- NSCLC Non-small cell lung cancer -- SCLC Small-cell lung cancer -- EGFR Epidermal growth factor receptor -- PFS Progression-free survival -- OS Overall survival -- EP Etoposide/platinum -- ICIs Immune checkpoint inhibitors -- PD-1 Programmed cell death-1 -- PD-L1 Programmed cell death-ligand 1 -- TMB Tumour mutational burden -- TILs Tumour-infiltrating lymphocytes -- RNA-seq RNA sequencing -- IHC Immunohistochemistry -- NGS Next-generation sequencing -- ARMS Amplification refractory mutation system -- TPS Tumour proportion score -- FFPE Formalin-fixed paraffin-embedded -- AUC Area under the curve -- AEs Adverse events -- SNVs Single nucleotide variants -- CCF Cancer cell fraction -- SCNV Somatic copy number variation -- CNV Copy number variation -- DEGs Differentially expressed genes -- pOS Post-T-SCLC overall survival -- ORR Objective response rate -- CR Complete response -- PR Partial response -- SD Stable disease -- PD Progressive diseases -- CEA Carcinoembryonic antigen -- NSE Neuron-specific enolase -- CT Computed tomography -- DCB Durable clinical benefit -- NDB No durable benefit -- ID6 Indel signature6 -- ID9 Indel signature9 -- HRD Homologous recombination deficiency -- TNB Tumour neoantigen burden -- GSEA Gene set enrichment analysis 1